The p53 tumor suppressor protein is a transcription factor with sequence-specific DNA binding activity that is thought to be important for the growth-inhibitory function of p53. DNA binding appears to require activation of a cryptic form of p53 by allosteric mechanisms involving a negative regulatory domain at the carboxyl terminus of p53. The latent form of p53, reactive to the carboxyl-terminal antibody PAb421, is produced in a variety of eukaryotic cells, suggesting that activation of p53 is an important rate-limiting step in vivo. In this report we provide evidence that phosphorylation of serine 378 within the carboxyl-terminal negative regulatory domain of the human p53 protein by protein kinase C correlates with loss of PAb421 reactivity and a concomitant activation of sequence-specific DNA binding. These effects are reversed by subsequent dephosphorylation of the protein kinase C-reactive site by protein phosphatases 1 (PP1) and 2A (PP2A), which restore the reactivity of p53 to PAb421 and regenerate the latent form of p53 lacking significant DNA binding activity. Thus, p53 is subject to both positive and negative regulation by reversible enzymatic modifications affecting the latent or active state of the protein, suggesting a possible mechanism for the regulation of its tumor suppressor function.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				I. Tchivilev, N. R. Madamanchi, A. E. Vendrov, X.-L. Niu, and M. S. Runge Identification of a Protective Role for Protein Phosphatase 1c{gamma}1 against Oxidative Stress-induced Vascular Smooth Muscle Cell Apoptosis J. Biol. Chem., August 8, 2008; 283(32): 22193 - 22205. [Abstract] [Full Text] [PDF]

				M. Sauer, A. C. Bretz, R. Beinoraviciute-Kellner, M. Beitzinger, C. Burek, A. Rosenwald, G. S. Harms, and T. Stiewe C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity Nucleic Acids Res., April 1, 2008; 36(6): 1900 - 1912. [Abstract] [Full Text] [PDF]

				L. E. Giono and J. J. Manfredi Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest Mol. Cell. Biol., June 1, 2007; 27(11): 4166 - 4178. [Abstract] [Full Text] [PDF]

				Y. Zhao, S. Lu, L. Wu, G. Chai, H. Wang, Y. Chen, J. Sun, Y. Yu, W. Zhou, Q. Zheng, et al. Acetylation of p53 at Lysine 373/382 by the Histone Deacetylase Inhibitor Depsipeptide Induces Expression of p21Waf1/Cip1. Mol. Cell. Biol., April 1, 2006; 26(7): 2782 - 2790. [Abstract] [Full Text] [PDF]

				S.-J. Lee, D.-C. Kim, B.-H. Choi, H. Ha, and K.-T. Kim Regulation of p53 by Activated Protein Kinase C-{delta} during Nitric Oxide-induced Dopaminergic Cell Death J. Biol. Chem., January 27, 2006; 281(4): 2215 - 2224. [Abstract] [Full Text] [PDF]

				N. Kim, W. Cao, I. S. Song, C. Y. Kim, K. M. Harnett, L. Cheng, M. P. Walsh, and P. Biancani Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles Am J Physiol Cell Physiol, August 1, 2004; 287(2): C384 - C394. [Abstract] [Full Text] [PDF]

				O. Pluquet, S. North, A. Bhoumik, K. Dimas, Z.'e. Ronai, and P. Hainaut The Cytoprotective Aminothiol WR1065 Activates p53 through a Non-genotoxic Signaling Pathway Involving c-Jun N-terminal Kinase J. Biol. Chem., March 28, 2003; 278(14): 11879 - 11887. [Abstract] [Full Text] [PDF]

				C. D. Braastad, Z. Han, and E. A. Hendrickson Constitutive DNase I Hypersensitivity of p53-Regulated Promoters J. Biol. Chem., February 28, 2003; 278(10): 8261 - 8268. [Abstract] [Full Text] [PDF]

				K. McKinney and C. Prives Efficient Specific DNA Binding by p53 Requires both Its Central and C-Terminal Domains as Revealed by Studies with High-Mobility Group 1 Protein Mol. Cell. Biol., October 1, 2002; 22(19): 6797 - 6808. [Abstract] [Full Text] [PDF]

				Q. Yang, R. Zhang, X. W. Wang, E. A. Spillare, S. P. Linke, D. Subramanian, J. D. Griffith, J. L. Li, I. D. Hickson, J. C. Shen, et al. The Processing of Holliday Junctions by BLM and WRN Helicases Is Regulated by p53 J. Biol. Chem., August 23, 2002; 277(35): 31980 - 31987. [Abstract] [Full Text] [PDF]

				C. D. Braastad, M. Leguia, and E. A. Hendrickson Ku86 autoantigen related protein-1 transcription initiates from a CpG island and is induced by p53 through a nearby p53 response element Nucleic Acids Res., April 15, 2002; 30(8): 1713 - 1724. [Abstract] [Full Text] [PDF]

				A. Friedler, L. O. Hansson, D. B. Veprintsev, S. M. V. Freund, T. M. Rippin, P. V. Nikolova, M. R. Proctor, S. Rudiger, and A. R. Fersht A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants PNAS, January 7, 2002; (2002) 241629998. [Abstract] [Full Text] [PDF]

				Y. Liu and M. Kulesz-Martin p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding Carcinogenesis, June 1, 2001; 22(6): 851 - 860. [Abstract] [Full Text] [PDF]

				T. Buschmann, O. Potapova, A. Bar-Shira, V. N. Ivanov, S. Y. Fuchs, S. Henderson, V. A. Fried, T. Minamoto, D. Alarcon-Vargas, M. R. Pincus, et al. Jun NH2-Terminal Kinase Phosphorylation of p53 on Thr-81 Is Important for p53 Stabilization and Transcriptional Activities in Response to Stress Mol. Cell. Biol., April 15, 2001; 21(8): 2743 - 2754. [Abstract] [Full Text]

				P. Arizti, L. Fang, I. Park, Y. Yin, E. Solomon, T. Ouchi, S. A. Aaronson, and S. W. Lee Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression Mol. Cell. Biol., October 15, 2000; 20(20): 7450 - 7459. [Abstract] [Full Text]

				K. Webley, J. A. Bond, C. J. Jones, J. P. Blaydes, A. Craig, T. Hupp, and D. Wynford-Thomas Posttranslational Modifications of p53 in Replicative Senescence Overlapping but Distinct from Those Induced by DNA Damage Mol. Cell. Biol., April 15, 2000; 20(8): 2803 - 2808. [Abstract] [Full Text]

				M. McVean, H. Xiao, K.-i. Isobe, and J. C. Pelling Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes Carcinogenesis, April 1, 2000; 21(4): 633 - 639. [Abstract] [Full Text] [PDF]

				G. Xiao, A. Chicas, M. Olivier, Y. Taya, S. Tyagi, F. R. Kramer, and J. Bargonetti A DNA Damage Signal Is Required for p53 to Activate gadd45 Cancer Res., March 1, 2000; 60(6): 1711 - 1719. [Abstract] [Full Text]

				A. Zaika, N. Marchenko, and U. M. Moll Cytoplasmically "Sequestered" Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation J. Biol. Chem., September 24, 1999; 274(39): 27474 - 27480. [Abstract] [Full Text] [PDF]

				A. M. Pierce, R. Schneider-Broussard, I. B. Gimenez-Conti, J. L. Russell, C. J. Conti, and D. G. Johnson E2F1 Has Both Oncogenic and Tumor-Suppressive Properties in a Transgenic Model Mol. Cell. Biol., September 1, 1999; 19(9): 6408 - 6414. [Abstract] [Full Text] [PDF]

				A. D. EVERETT, C. XUE, and T. STOOPS Developmental Expression of Protein Phosphatase 2A in the Kidney J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1737 - 1745. [Abstract] [Full Text]

				K. W. Kohn Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734. [Abstract] [Full Text]

				T.-c. Hsieh, G. Juan, Z. Darzynkiewicz, and J. M. Wu Resveratrol Increases Nitric Oxide Synthase, Induces Accumulation of p53 and p21WAF1/CIP1, and Suppresses Cultured Bovine Pulmonary Artery EndothelialCell Proliferation by Perturbing Progression through S and G2 Cancer Res., June 1, 1999; 59(11): 2596 - 2601. [Abstract] [Full Text] [PDF]

				J. Xu and G. F. Morris p53-Mediated Regulation of Proliferating Cell Nuclear Antigen Expression in Cells Exposed to Ionizing Radiation Mol. Cell. Biol., January 1, 1999; 19(1): 12 - 20. [Abstract] [Full Text] [PDF]

				H.-y. Tang, K. Zhao, J. F. Pizzolato, M. Fonarev, J. C. Langer, and J. J. Manfredi Constitutive Expression of the Cyclin-dependent Kinase Inhibitor p21 Is Transcriptionally Regulated by the Tumor Suppressor Protein p53 J. Biol. Chem., October 30, 1998; 273(44): 29156 - 29163. [Abstract] [Full Text] [PDF]

				M. Baumann, H. Mischak, S. Dammeier, W. Kolch, O. Gires, D. Pich, R. Zeidler, H.-J. Delecluse, and W. Hammerschmidt Activation of the Epstein-Barr Virus Transcription Factor BZLF1 by 12-O-Tetradecanoylphorbol-13-Acetate-Induced Phosphorylation J. Virol., October 1, 1998; 72(10): 8105 - 8114. [Abstract] [Full Text] [PDF]

				A. J. Giaccia and M. B. Kastan The complexity of p53 modulation: emerging patterns from divergent signals Genes & Dev., October 1, 1998; 12(19): 2973 - 2983. [Full Text]

				K. Sakaguchi, J. E. Herrera, S.'i. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella DNA damage activates p53 through a phosphorylation-acetylation cascade Genes & Dev., September 15, 1998; 12(18): 2831 - 2841. [Abstract] [Full Text]

				S.-H. Liang, D. Hong, and M. F. Clarke Cooperation of a Single Lysine Mutation and a C-terminal Domain in the Cytoplasmic Sequestration of the p53 Protein J. Biol. Chem., July 31, 1998; 273(31): 19817 - 19821. [Abstract] [Full Text] [PDF]

				L. Resnick-Silverman, S. St. Clair, M. Maurer, K. Zhao, and J. J. Manfredi Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53 Genes & Dev., July 15, 1998; 12(14): 2102 - 2107. [Abstract] [Full Text]

				M. L. Kelly, Y. Tang, N. Rosensweig, S. Clejan, and B. S. Beckman Granulocyte-Macrophage Colony-Stimulating Factor Rescues TF-1 Leukemia Cells From Ionizing Radiation-Induced Apoptosis Through a Pathway Mediated by Protein Kinase Calpha Blood, July 15, 1998; 92(2): 416 - 424. [Abstract] [Full Text] [PDF]

				B. F. Muller-Tiemann, T. D. Halazonetis, and J. J. Elting Identification of an additional negative regulatory region for p53 sequence-specific DNA binding PNAS, May 26, 1998; 95(11): 6079 - 6084. [Abstract] [Full Text] [PDF]

				Z. Zuo, N. M. Dean, and R. E. Honkanen Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest J. Biol. Chem., May 15, 1998; 273(20): 12250 - 12258. [Abstract] [Full Text] [PDF]

				M. Malanga, J. M. Pleschke, H. E. Kleczkowska, and F. R. Althaus Poly(ADP-ribose) Binds to Specific Domains of p53 and Alters Its DNA Binding Functions J. Biol. Chem., May 8, 1998; 273(19): 11839 - 11843. [Abstract] [Full Text] [PDF]

				M. Kapoor and G. Lozano Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma  radiation PNAS, March 17, 1998; 95(6): 2834 - 2837. [Abstract] [Full Text] [PDF]

				J. D. Siliciano, C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M. B. Kastan DNA damage induces phosphorylation of the amino terminus of p53 Genes & Dev., December 15, 1997; 11(24): 3471 - 3481. [Abstract] [Full Text] [PDF]

				A. M. Fourie, T. R. Hupp, D. P. Lane, B.-C. Sang, M. S. Barbosa, J. F. Sambrook, and M.-J. H. Gething HSP70 Binding Sites in the Tumor Suppressor Protein p53 J. Biol. Chem., August 1, 1997; 272(31): 19471 - 19479. [Abstract] [Full Text] [PDF]

				C. J. Thut, J. A. Goodrich, and R. Tjian Repression of p53-mediated transcription by MDM2: a dual mechanism Genes & Dev., August 1, 1997; 11(15): 1974 - 1986. [Abstract] [Full Text] [PDF]

				Y. Yan, J. W. Shay, W. E. Wright, and M. C. Mumby Inhibition of Protein Phosphatase Activity Induces p53-dependent Apoptosis in the Absence of p53 Transactivation J. Biol. Chem., June 13, 1997; 272(24): 15220 - 15226. [Abstract] [Full Text] [PDF]

				M. R. Frey, M. L. Saxon, X. Zhao, A. Rollins, S. S. Evans, and J. D. Black Protein Kinase C Isozyme-mediated Cell Cycle Arrest Involves Induction of p21waf1/cip1 and p27kip1 and Hypophosphorylation of the Retinoblastoma Protein in Intestinal Epithelial Cells J. Biol. Chem., April 4, 1997; 272(14): 9424 - 9435. [Abstract] [Full Text] [PDF]

				S. Hansen, C. A. Midgley, D. P. Lane, B. C. Freeman, R. I. Morimoto, and T. R. Hupp Modification of Two Distinct COOH-terminal Domains Is Required for Murine p53 Activation by Bacterial Hsp70 J. Biol. Chem., November 29, 1996; 271(48): 30922 - 30928. [Abstract] [Full Text] [PDF]

				X W Wang, W Vermeulen, J D Coursen, M Gibson, S E Lupold, K Forrester, G Xu, L Elmore, H Yeh, J H Hoeijmakers, et al. The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes & Dev., May 15, 1996; 10(10): 1219 - 1232. [Abstract] [PDF]

				S. Hansen, T. R. Hupp, and D. P. Lane Allosteric Regulation of the Thermostability and DNA Binding Activity of Human p53 by Specific Interacting Proteins J. Biol. Chem., February 16, 1996; 271(7): 3917 - 3924. [Abstract] [Full Text] [PDF]

				C. Cain, S. Miller, J. Ahn, and C. Prives The N Terminus of p53 Regulates Its Dissociation from DNA J. Biol. Chem., December 15, 2000; 275(51): 39944 - 39953. [Abstract] [Full Text] [PDF]

				T. Imamura, H. Izumi, G. Nagatani, T. Ise, M. Nomoto, Y. Iwamoto, and K. Kohno Interaction with p53 Enhances Binding of Cisplatin-modified DNA by High Mobility Group 1 Protein J. Biol. Chem., March 2, 2001; 276(10): 7534 - 7540. [Abstract] [Full Text] [PDF]

				A. Lakkaraju, J. M. Dubinsky, W. C. Low, and Y.-E. Rahman Neurons Are Protected from Excitotoxic Death by p53 Antisense Oligonucleotides Delivered in Anionic Liposomes J. Biol. Chem., August 17, 2001; 276(34): 32000 - 32007. [Abstract] [Full Text] [PDF]

				A. Friedler, L. O. Hansson, D. B. Veprintsev, S. M. V. Freund, T. M. Rippin, P. V. Nikolova, M. R. Proctor, S. Rudiger, and A. R. Fersht A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants PNAS, January 22, 2002; 99(2): 937 - 942. [Abstract] [Full Text] [PDF]